Professor Richard Coward, Children's Renal Unit, Bristol Royal Hospital for Children
MRC INTEGRATIVE EPIDEMIOLOGY UNIT (IEU)
Thursday, 21st September, 2017 : Room BG10
Ground Floor, Barley House
16.00 – 1700
Professor of Renal Mediciane and Consultant
University of Bristol
"Podocytes, Proteinuria and Populations”
Proteinuria is a global health care issue as it is independently linked to end stage renal disease, cardiovascular dysfunction and death.
This talk will explore some of the important molecular signalling pathways that we have discovered in Bristol Renal using human, mouse and drosophila in vitro and in vivo podocyte cell models.
It will focus on diabetic nephropathy which is the leading cause of kidney failure, requiring a kidney transplant or dialysis, in the world.
Richard studied medicine Bristol University and then trained as a Paediatric Nephrologist in the South West of England, Great Ormond Street and the Starship hospital in Aukland, New Zealand. At the end of his clinical training (in 2001) he decided to undertake a PhD in Bristol which was funded by the Royal College of Paediatrics studying the molecular biology of the podocyte. In 2005 he was awarded an MRC Clinician Scientist Fellowship to extend his work and this allowed him to go to Toronto for 2- years to work in the world leading glomerular transgenic mouse laboratory with Professor Susan Quaggin. In 2013 he was awarded an MRC Senior Clinical Fellowship to establish his own group.
Richard was head of Research in the School of Clinical Sciences for the last REF and sits on a number of scientific committees including the MRC PSMB grant committee, the Newton fund, Kidney Research UK, and was the chair of the Genome Editing Mice for Medicine call in 2017. He is also the European co-lead for the Scientific modelling work-package of the BEAt-DKD (beat diabetic kidney disease). This is a 27 million Euro project looking for biomarkers and underpinning mechanisms of diabetic kidney disease in Europe.
He, unfortunately, supports Leeds United.